New diabetes clinical trial: A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

Published on: January 12, 2025 at 11:00PM
Conditions: Diabetic Retinopathy; NPDR - Non Proliferative Diabetic Retinopathy
Interventions: Drug: VX-01; Drug: Placebo
Sponsors: Vantage Biosciences Ltd; Vantage Biosciences Australia Pty Ltd
Recruiting
https://ift.tt/8Cg6xpW